The role of circRNA in breast cancer drug resistance
Among women with cancer, breast cancer has surpassed lung cancer to become the most prevalent type of cancer globally. High-throughput sequencing of breast cancer tissues from many patients has revealed significant variations in circRNA expression across different types of breast cancer. Chemotherap...
Saved in:
| Main Authors: | , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
PeerJ Inc.
2024-12-01
|
| Series: | PeerJ |
| Subjects: | |
| Online Access: | https://peerj.com/articles/18733.pdf |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1850101027558129664 |
|---|---|
| author | Shaofeng Yang Donghai Li |
| author_facet | Shaofeng Yang Donghai Li |
| author_sort | Shaofeng Yang |
| collection | DOAJ |
| description | Among women with cancer, breast cancer has surpassed lung cancer to become the most prevalent type of cancer globally. High-throughput sequencing of breast cancer tissues from many patients has revealed significant variations in circRNA expression across different types of breast cancer. Chemotherapy is currently a very important method for treating breast cancer; however, as the number of chemotherapy sessions increases and considering factors such as the patient’s immune response, drug resistance has become a challenging issue in treating breast cancer. It is well known that drug resistance is associated with multiple factors, and different resistance mechanisms involve different roles of circRNA. This review consolidates literature from the past 5 years and addresses the shortcomings in the broad description of circRNA’s role in breast cancer drug resistance. It categorizes and describes the drug resistance and its mechanisms in different types of breast cancer, as well as the roles of circRNA and signaling pathways in drug resistance. |
| format | Article |
| id | doaj-art-3f7c5a8513c34590b3614f6a2e6c7542 |
| institution | DOAJ |
| issn | 2167-8359 |
| language | English |
| publishDate | 2024-12-01 |
| publisher | PeerJ Inc. |
| record_format | Article |
| series | PeerJ |
| spelling | doaj-art-3f7c5a8513c34590b3614f6a2e6c75422025-08-20T02:40:08ZengPeerJ Inc.PeerJ2167-83592024-12-0112e1873310.7717/peerj.18733The role of circRNA in breast cancer drug resistanceShaofeng YangDonghai LiAmong women with cancer, breast cancer has surpassed lung cancer to become the most prevalent type of cancer globally. High-throughput sequencing of breast cancer tissues from many patients has revealed significant variations in circRNA expression across different types of breast cancer. Chemotherapy is currently a very important method for treating breast cancer; however, as the number of chemotherapy sessions increases and considering factors such as the patient’s immune response, drug resistance has become a challenging issue in treating breast cancer. It is well known that drug resistance is associated with multiple factors, and different resistance mechanisms involve different roles of circRNA. This review consolidates literature from the past 5 years and addresses the shortcomings in the broad description of circRNA’s role in breast cancer drug resistance. It categorizes and describes the drug resistance and its mechanisms in different types of breast cancer, as well as the roles of circRNA and signaling pathways in drug resistance.https://peerj.com/articles/18733.pdfBCcircRNADrug resistanceAntineoplastic |
| spellingShingle | Shaofeng Yang Donghai Li The role of circRNA in breast cancer drug resistance PeerJ BC circRNA Drug resistance Antineoplastic |
| title | The role of circRNA in breast cancer drug resistance |
| title_full | The role of circRNA in breast cancer drug resistance |
| title_fullStr | The role of circRNA in breast cancer drug resistance |
| title_full_unstemmed | The role of circRNA in breast cancer drug resistance |
| title_short | The role of circRNA in breast cancer drug resistance |
| title_sort | role of circrna in breast cancer drug resistance |
| topic | BC circRNA Drug resistance Antineoplastic |
| url | https://peerj.com/articles/18733.pdf |
| work_keys_str_mv | AT shaofengyang theroleofcircrnainbreastcancerdrugresistance AT donghaili theroleofcircrnainbreastcancerdrugresistance AT shaofengyang roleofcircrnainbreastcancerdrugresistance AT donghaili roleofcircrnainbreastcancerdrugresistance |